ReFacto^® Antihemophilic Factor (Recombinant)

Product Overview

ReFacto^® Antihemophilic Factor (Recombinant)

For additional product information, please visit www.hemophiliavillage.com

Please note that ReFacto will no longer be available as of May 31, 2009. Please contact Global Medical Communications at 1-800-934-5556 for more information.

Indication and Usage

ReFacto is indicated for the control and prevention of hemorrhagic episodes and for surgical prophylaxis and for short-term routine prophylaxis to reduce the frequency of spontaneous bleeding episodes in patients with hemophilia A. The effect of regular routine prophylaxis on long-term morbidity and mortality is unknown.

Important Safety Information

• As with the intravenous administration of any protein product, adverse reactions may include headache, fever, chills, flushing, nausea, vomiting, tiredness, or symptoms of allergic reactions.
• The remote possibility exists for hypersensitivity to non-human mammalian proteins. Known hypersensitivity to mouse or hamster proteins may be a contraindication to the use of ReFacto.
• Allergic reactions such as hives, itching, difficulty breathing, rapid heart rate, light-headedness and anaphylaxis have been reported for all factor VIII products. Patients should discontinue use of the product and contact their health care provider immediately and/or seek emergency care if any of these symptoms occur.

Please see full Prescribing Information.

241026-01

How helpful was this article to you or your practice?